By Diana Novak Jones
-A federal judge in Texas has upheld the U.S. Food and Drug Administration’s decision to remove Novo Nordisk’s blockbuster drugs Ozempic and Wegovy from the drug shortage list, rejecting a challenge brought by compounding pharmacies who sought to continue making copies of the drugs.
(Reporting by Diana Novak Jones in Chicago)
Brought to you by www.srnnews.com
